Insider Selling: Kevin J. Kenny Sells 15,484 Shares of Cardiovascular Systems Stock (CSII)
Cardiovascular Systems (NASDAQ:CSII) VP Kevin J. Kenny unloaded 15,484 shares of the stock on the open market in a transaction dated Friday, April 25th. The shares were sold at an average price of $28.79, for a total value of $445,784.36. Following the sale, the vice president now directly owns 66,841 shares of the company’s stock, valued at approximately $1,924,352. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Cardiovascular Systems (NASDAQ:CSII) traded down 2.47% during mid-day trading on Monday, hitting $28.02. 311,327 shares of the company’s stock traded hands. Cardiovascular Systems has a one year low of $16.66 and a one year high of $37.73. The stock has a 50-day moving average of $30.79 and a 200-day moving average of $31.06. The company’s market cap is $840.6 million.
Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings results on Wednesday, January 29th. The company reported ($0.32) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.34) by $0.02. The company had revenue of $32.30 million for the quarter, compared to the consensus estimate of $30.62 million. Cardiovascular Systems’s revenue was up 27.7% compared to the same quarter last year. Analysts expect that Cardiovascular Systems will post $-1.23 EPS for the current fiscal year.
A number of analysts have recently weighed in on CSII shares. Analysts at Needham & Company LLC initiated coverage on shares of Cardiovascular Systems in a research note on Friday, March 21st. They set a “strong-buy” rating and a $47.00 price target on the stock. Separately, analysts at Zacks downgraded shares of Cardiovascular Systems from an “outperform” rating to a “neutral” rating in a research note on Wednesday, February 5th. They now have a $36.80 price target on the stock. Finally, analysts at Benchmark Co. upgraded shares of Cardiovascular Systems from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. They now have a $38.00 price target on the stock, up previously from $35.00. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and two have given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $41.30.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.